In pharmaceutical microbiology, environmental monitoring (EM) is a cornerstone of contamination control and quality assurance. Culture media, used to recover and enumerate viable microorganisms from controlled environments, plays a critical role in the reliability of EM results. Given its impact on product safety and regulatory compliance, sourcing culture media from a reliable and validated supplier is essential. Equally important, however, is the validation of a second supplier. This step, often overlooked or delayed, is vital for ensuring production continuity and mitigating supply chain risks.
This webinar offers an in-depth look at:
- Why relying on a single supplier for culture media is a high-risk strategy.
- How global regulatory bodies, including the FDA, EMA, and PIC/S, expect pharmaceutical companies to manage supplier risks proactively.
- How, by qualifying a second supplier, pharmaceutical companies can build resilience into their supply chain.
- Why validating a second supplier of culture media for environmental monitoring is not a procurement strategy but a quality imperative.
Can’t make it? Register anyway, and we’ll send you the recording.
